User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): Data from an international survey rmer and linsberger user satisfaction with the LNG-IUS

European Journal of Contraception and Reproductive Health Care

Volumn 14, Issue 6, 2009, Pages 391-398

  Römer, Thomas ^a   Linsberger, Doris ^b  

^a Evangelisches Krankenhaus Koln Weyertal   (Germany)

^b NONE   (Austria)

Author keywords

Contraception; Intrauterine device (IUD); Levonorgestrel releasing intrauterine system (LNG IUS); Long acting reversible contraceptive (LARC)

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CONTRACEPTION; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; EUROPE; EXPERIENCE; FAMILY PLANNING; FEMALE; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION; PATIENT SATISFACTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE;

ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; EUROPE; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUESTIONNAIRES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 71049186370     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625180903203154     Document Type: Article

References (18)

1. Oddens BJ, Lehert P. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. I: Demographic factors. J Biosoc Sci 1997;29: 415-435
2. Skouby SO. Contraceptive use and behavior in the 21st century: A comprehensive study across five European countries. Eur J Contracept Reprod Health Care 2004;9:57-68.
3. Spinelli A, Talamanca IF, Lauria L. Patterns of contraceptive use in 5 European countries. European Study Group on Infertility and Subfecundity. Am J Public Health 2000;90:1403-1408
4. Cibula D. Women's contraceptive practices and sexual behaviour in Europe. Eur J Contracept Reprod Health Care 2008;13:362-375
5. Oddens BJ. Determinants of contraceptive use among women of reproductive age in GreatBritain andGermany. II: Psychological factors. J Biosoc Sci 1997;29:437-470
6. Serbanescu F, Goldberg H, Morris L. Reproductive health in the transition countries of Europe. In Macura M, MacDonald A, Haug W, eds. The new demographic regime: Population challenges and policy responses. Geneva: United Nations, 2005:177-198
7. Batar I. State-of-the-art of intrauterine contraception. Eur J Contracept Reprod Health Care 2006;11:262-269
8. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 2007;75:S161-6.
9. Andersson K, Odlind V, Rybo G. Levonorgestrelreleasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72.
10. Jensen JT. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: An overview. Obstet Gynecol Surv 2005;60:604-612
11. Kriplani A, Singh BM, Lal S, et al. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet 2007;97:190-194
12. Vercellini P, Vigano P, Somigliana E. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis. Curr Opin Obstet Gynecol 2005;17:359-365
13. Haimovich S. Profile of long-acting reversible contraception users in Europe. Eur J Contracept Reprod Health Care 2009;14:187-195
14. Prager S,Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception 2007;75:S12-5.
15. Suhonen S, Haukkamaa M, Jakobsson T, et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004;69:407-412
16. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol 2007;110:1493-1495
17. Belhadj H, Sivin I,Diaz S, et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986;34:261-267
18. Sivin I, Stern J, Diaz S, et al. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 1992;166:1208-1213